Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  HIV Infection

  Free Subscription


Articles published in PLoS Med

Retrieve available abstracts of 88 articles:
HTML format
Text format



Single Articles


    August 2018
  1. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Correction: Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002643.
    PubMed     Text format     Abstract available


  2. ZANOLINI A, Sikombe K, Sikazwe I, Eshun-Wilson I, et al
    Understanding preferences for HIV care and treatment in Zambia: Evidence from a discrete choice experiment among patients who have been lost to follow-up.
    PLoS Med. 2018;15:e1002636.
    PubMed     Text format     Abstract available


    July 2018
  3. HARAUSZ EP, Garcia-Prats AJ, Law S, Schaaf HS, et al
    Treatment and outcomes in children with multidrug-resistant tuberculosis: A systematic review and individual patient data meta-analysis.
    PLoS Med. 2018;15:e1002591.
    PubMed     Text format     Abstract available


    June 2018
  4. MODY A, Sikazwe I, Czaicki NL, Wa Mwanza M, et al
    Estimating the real-world effects of expanding antiretroviral treatment eligibility: Evidence from a regression discontinuity analysis in Zambia.
    PLoS Med. 2018;15:e1002574.
    PubMed     Text format     Abstract available


  5. FOX MP, Bor J, Brennan AT, MacLeod WB, et al
    Estimating retention in HIV care accounting for patient transfers: A national laboratory cohort study in South Africa.
    PLoS Med. 2018;15:e1002589.
    PubMed     Text format     Abstract available


  6. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Correction: Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002608.
    PubMed     Text format     Abstract available


    May 2018
  7. DESMONDE S, Tanser F, Vreeman R, Takassi E, et al
    Access to antiretroviral therapy in HIV-infected children aged 0-19 years in the International Epidemiology Databases to Evaluate AIDS (IeDEA) Global Cohort Consortium, 2004-2015: A prospective cohort study.
    PLoS Med. 2018;15:e1002565.
    PubMed     Text format     Abstract available


    March 2018
  8. PATEL P, Speight C, Maida A, Loustalot F, et al
    Integrating HIV and hypertension management in low-resource settings: Lessons from Malawi.
    PLoS Med. 2018;15:e1002523.
    PubMed     Text format     Abstract available


  9. SLOGROVE AL, Schomaker M, Davies MA, Williams P, et al
    The epidemiology of adolescents living with perinatally acquired HIV: A cross-region global cohort analysis.
    PLoS Med. 2018;15:e1002514.
    PubMed     Text format     Abstract available


  10. MYER L, Phillips TK, Zerbe A, Brittain K, et al
    Integration of postpartum healthcare services for HIV-infected women and their infants in South Africa: A randomised controlled trial.
    PLoS Med. 2018;15:e1002547.
    PubMed     Text format     Abstract available


  11. STEKLER JD, Milne R, Payant R, Beck I, et al
    Transmission of HIV-1 drug resistance mutations within partner-pairs: A cross-sectional study of a primary HIV infection cohort.
    PLoS Med. 2018;15:e1002537.
    PubMed     Text format     Abstract available


  12. TYMEJCZYK O, Brazier E, Yiannoutsos C, Wools-Kaloustian K, et al
    HIV treatment eligibility expansion and timely antiretroviral treatment initiation following enrollment in HIV care: A metaregression analysis of programmatic data from 22 countries.
    PLoS Med. 2018;15:e1002534.
    PubMed     Text format     Abstract available


    February 2018
  13. TORRONE EA, Morrison CS, Chen PL, Kwok C, et al
    Prevalence of sexually transmitted infections and bacterial vaginosis among women in sub-Saharan Africa: An individual participant data meta-analysis of 18 HIV prevention studies.
    PLoS Med. 2018;15:e1002511.
    PubMed     Text format     Abstract available


  14. FRANCIS SC, Mthiyane TN, Baisley K, Mchunu SL, et al
    Prevalence of sexually transmitted infections among young people in South Africa: A nested survey in a health and demographic surveillance site.
    PLoS Med. 2018;15:e1002512.
    PubMed     Text format     Abstract available


    January 2018
  15. MARRAZZO JM, Dombrowski JC, Mayer KH
    Sexually transmitted infections in the era of antiretroviral-based HIV prevention: Priorities for discovery research, implementation science, and community involvement.
    PLoS Med. 2018;15:e1002485.
    PubMed     Text format     Abstract available


  16. HOLMES CB, Sikazwe I, Sikombe K, Eshun-Wilson I, et al
    Estimated mortality on HIV treatment among active patients and patients lost to follow-up in 4 provinces of Zambia: Findings from a multistage sampling-based survey.
    PLoS Med. 2018;15:e1002489.
    PubMed     Text format     Abstract available


  17. GAUDINSKI MR, Coates EE, Houser KV, Chen GL, et al
    Safety and pharmacokinetics of the Fc-modified HIV-1 human monoclonal antibody VRC01LS: A Phase 1 open-label clinical trial in healthy adults.
    PLoS Med. 2018;15:e1002493.
    PubMed     Text format     Abstract available


  18. JUDD A, Chappell E, Turkova A, Le Coeur S, et al
    Long-term trends in mortality and AIDS-defining events after combination ART initiation among children and adolescents with perinatal HIV infection in 17 middle- and high-income countries in Europe and Thailand: A cohort study.
    PLoS Med. 2018;15:e1002491.
    PubMed     Text format     Abstract available


    December 2017
  19. DUBE K, Sylla L, Dee L, Taylor J, et al
    Research on HIV cure: Mapping the ethics landscape.
    PLoS Med. 2017;14:e1002470.
    PubMed     Text format     Abstract available


  20. KENDALL EA, Schumacher SG, Denkinger CM, Dowdy DW, et al
    Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.
    PLoS Med. 2017;14:e1002472.
    PubMed     Text format     Abstract available


  21. SUTHAR AB, Barnighausen T
    Antiretroviral therapy and population mortality: Leveraging routine national data to advance policy.
    PLoS Med. 2017;14:e1002469.
    PubMed     Text format     Abstract available


  22. JOHNSON LF, May MT, Dorrington RE, Cornell M, et al
    Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.
    PLoS Med. 2017;14:e1002468.
    PubMed     Text format     Abstract available


  23. CHESANG K, Hornston S, Muhenje O, Saliku T, et al
    Healthcare provider perspectives on managing sexually transmitted infections in HIV care settings in Kenya: A qualitative thematic analysis.
    PLoS Med. 2017;14:e1002480.
    PubMed     Text format     Abstract available


  24. WILSON E, Free C, Morris TP, Syred J, et al
    Internet-accessed sexually transmitted infection (e-STI) testing and results service: A randomised, single-blind, controlled trial.
    PLoS Med. 2017;14:e1002479.
    PubMed     Text format     Abstract available


  25. JOHNSTON C, Magaret A, Roychoudhury P, Greninger AL, et al
    Dual-strain genital herpes simplex virus type 2 (HSV-2) infection in the US, Peru, and 8 countries in sub-Saharan Africa: A nested cross-sectional viral genotyping study.
    PLoS Med. 2017;14:e1002475.
    PubMed     Text format     Abstract available


    November 2017
  26. CASTILLO P, Hurtado JC, Martinez MJ, Jordao D, et al
    Validity of a minimally invasive autopsy for cause of death determination in maternal deaths in Mozambique: An observational study.
    PLoS Med. 2017;14:e1002431.
    PubMed     Text format     Abstract available


  27. MCNAIRY ML, Lamb MR, Gachuhi AB, Nuwagaba-Biribonwoha H, et al
    Effectiveness of a combination strategy for linkage and retention in adult HIV care in Swaziland: The Link4Health cluster randomized trial.
    PLoS Med. 2017;14:e1002420.
    PubMed     Text format     Abstract available


  28. BOYD MA, Mocroft A, Ryom L, Monforte AD, et al
    Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study.
    PLoS Med. 2017;14:e1002424.
    PubMed     Text format     Abstract available


  29. HENRICH TJ, Hatano H, Bacon O, Hogan LE, et al
    HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study.
    PLoS Med. 2017;14:e1002417.
    PubMed     Text format     Abstract available


  30. KAPLAN SR, Oosthuizen C, Stinson K, Little F, et al
    Contemporary disengagement from antiretroviral therapy in Khayelitsha, South Africa: A cohort study.
    PLoS Med. 2017;14:e1002407.
    PubMed     Text format     Abstract available


  31. EL-SADR WM, Harripersaud K, Rabkin M
    Reaching global HIV/AIDS goals: What got us here, won't get us there.
    PLoS Med. 2017;14:e1002421.
    PubMed     Text format     Abstract available


  32. POTEAT T, Ackerman B, Diouf D, Ceesay N, et al
    HIV prevalence and behavioral and psychosocial factors among transgender women and cisgender men who have sex with men in 8 African countries: A cross-sectional analysis.
    PLoS Med. 2017;14:e1002422.
    PubMed     Text format     Abstract available


  33. MAYER KH, Seaton KE, Huang Y, Grunenberg N, et al
    Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
    PLoS Med. 2017;14:e1002435.
    PubMed     Text format     Abstract available


  34. SZUBERT AJ, Prendergast AJ, Spyer MJ, Musiime V, et al
    Virological response and resistance among HIV-infected children receiving long-term antiretroviral therapy without virological monitoring in Uganda and Zimbabwe: Observational analyses within the randomised ARROW trial.
    PLoS Med. 2017;14:e1002432.
    PubMed     Text format     Abstract available


  35. MORRIS L, Mkhize NN
    Prospects for passive immunity to prevent HIV infection.
    PLoS Med. 2017;14:e1002436.
    PubMed     Text format     Abstract available


  36. KATZ IT, Kaplan R, Fitzmaurice G, Leone D, et al
    Treatment guidelines and early loss from care for people living with HIV in Cape Town, South Africa: A retrospective cohort study.
    PLoS Med. 2017;14:e1002434.
    PubMed     Text format     Abstract available


  37. ELUL B, Lamb MR, Lahuerta M, Abacassamo F, et al
    A combination intervention strategy to improve linkage to and retention in HIV care following diagnosis in Mozambique: A cluster-randomized study.
    PLoS Med. 2017;14:e1002433.
    PubMed     Text format     Abstract available


  38. BARNABAS RV, Celum C
    Closing the gaps in the HIV care continuum.
    PLoS Med. 2017;14:e1002443.
    PubMed     Text format     Abstract available


  39. DUNNING L, Francke JA, Mallampati D, MacLean RL, et al
    The value of confirmatory testing in early infant HIV diagnosis programmes in South Africa: A cost-effectiveness analysis.
    PLoS Med. 2017;14:e1002446.
    PubMed     Text format     Abstract available


  40. CHANDA MM, Ortblad KF, Mwale M, Chongo S, et al
    HIV self-testing among female sex workers in Zambia: A cluster randomized controlled trial.
    PLoS Med. 2017;14:e1002442.
    PubMed     Text format     Abstract available


  41. EAKLE R, Gomez GB, Naicker N, Bothma R, et al
    HIV pre-exposure prophylaxis and early antiretroviral treatment among female sex workers in South Africa: Results from a prospective observational demonstration project.
    PLoS Med. 2017;14:e1002444.
    PubMed     Text format     Abstract available


  42. DEEKS SG, Lewin SR, Bekker LG
    The end of HIV: Still a very long way to go, but progress continues.
    PLoS Med. 2017;14:e1002466.
    PubMed     Text format     Abstract available


  43. BOR J, Fox MP, Rosen S, Venkataramani A, et al
    Treatment eligibility and retention in clinical HIV care: A regression discontinuity study in South Africa.
    PLoS Med. 2017;14:e1002463.
    PubMed     Text format     Abstract available


  44. SOLOMON SS, McFall AM, Lucas GM, Srikrishnan AK, et al
    Respondent-driven sampling for identification of HIV- and HCV-infected people who inject drugs and men who have sex with men in India: A cross-sectional, community-based analysis.
    PLoS Med. 2017;14:e1002460.
    PubMed     Text format     Abstract available


  45. ORTBLAD K, Kibuuka Musoke D, Ngabirano T, Nakitende A, et al
    Direct provision versus facility collection of HIV self-tests among female sex workers in Uganda: A cluster-randomized controlled health systems trial.
    PLoS Med. 2017;14:e1002458.
    PubMed     Text format     Abstract available


  46. CUMMINS NW, Rizza S, Litzow MR, Hua S, et al
    Extensive virologic and immunologic characterization in an HIV-infected individual following allogeneic stem cell transplant and analytic cessation of antiretroviral therapy: A case study.
    PLoS Med. 2017;14:e1002461.
    PubMed     Text format     Abstract available


  47. BEYRER C, Wirtz AL, O'Hara G, Leon N, et al
    The expanding epidemic of HIV-1 in the Russian Federation.
    PLoS Med. 2017;14:e1002462.
    PubMed     Text format     Abstract available


    August 2017
  48. DE NEVE JW, Garrison-Desany H, Andrews KG, Sharara N, et al
    Harmonization of community health worker programs for HIV: A four-country qualitative study in Southern Africa.
    PLoS Med. 2017;14:e1002374.
    PubMed     Text format     Abstract available


  49. MYER L, Essajee S, Broyles LN, Watts DH, et al
    Pregnant and breastfeeding women: A priority population for HIV viral load monitoring.
    PLoS Med. 2017;14:e1002375.
    PubMed     Text format     Abstract available


    July 2017
  50. KARWA R, Maina M, Mercer T, Njuguna B, et al
    Leveraging peer-based support to facilitate HIV care in Kenya.
    PLoS Med. 2017;14:e1002355.
    PubMed     Text format     Abstract available


  51. ALIROL E, Wi TE, Bala M, Bazzo ML, et al
    Multidrug-resistant gonorrhea: A research and development roadmap to discover new medicines.
    PLoS Med. 2017;14:e1002366.
    PubMed     Text format     Abstract available


  52. KOENIG SP, Dorvil N, Devieux JG, Hedt-Gauthier BL, et al
    Same-day HIV testing with initiation of antiretroviral therapy versus standard care for persons living with HIV: A randomized unblinded trial.
    PLoS Med. 2017;14:e1002357.
    PubMed     Text format     Abstract available


  53. SIMMS V, Dauya E, Dakshina S, Bandason T, et al
    Community burden of undiagnosed HIV infection among adolescents in Zimbabwe following primary healthcare-based provider-initiated HIV testing and counselling: A cross-sectional survey.
    PLoS Med. 2017;14:e1002360.
    PubMed     Text format     Abstract available


  54. GENG EH, Havlir DV
    The science of rapid start-From the when to the how of antiretroviral initiation.
    PLoS Med. 2017;14:e1002358.
    PubMed     Text format     Abstract available


  55. LIGHTFOOT M, Dunbar M, Weiser SD
    Reducing undiagnosed HIV infection among adolescents in sub-Saharan Africa: Provider-initiated and opt-out testing are not enough.
    PLoS Med. 2017;14:e1002361.
    PubMed     Text format     Abstract available


    June 2017
  56. MAHEU-GIROUX M, Vesga JF, Diabate S, Alary M, et al
    Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Cote d'Ivoire: Insights from mathematical modeling.
    PLoS Med. 2017;14:e1002321.
    PubMed     Text format     Abstract available


  57. TAYLOR M, Newman L, Ishikawa N, Laverty M, et al
    Elimination of mother-to-child transmission of HIV and Syphilis (EMTCT): Process, progress, and program integration.
    PLoS Med. 2017;14:e1002329.
    PubMed     Text format     Abstract available


    May 2017
  58. HAYES R, Floyd S, Schaap A, Shanaube K, et al
    A universal testing and treatment intervention to improve HIV control: One-year results from intervention communities in Zambia in the HPTN 071 (PopART) cluster-randomised trial.
    PLoS Med. 2017;14:e1002292.
    PubMed     Text format     Abstract available


  59. IWUJI C, Newell ML
    Towards control of the global HIV epidemic: Addressing the middle-90 challenge in the UNAIDS 90-90-90 target.
    PLoS Med. 2017;14:e1002293.
    PubMed     Text format     Abstract available


  60. BERNARD CL, Owens DK, Goldhaber-Fiebert JD, Brandeau ML, et al
    Estimation of the cost-effectiveness of HIV prevention portfolios for people who inject drugs in the United States: A model-based analysis.
    PLoS Med. 2017;14:e1002312.
    PubMed     Text format     Abstract available


    April 2017
  61. GRANICH R, Gupta S, Hall I, Aberle-Grasse J, et al
    Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review.
    PLoS Med. 2017;14:e1002253.
    PubMed     Text format     Abstract available


  62. FOX MP, Rosen S
    A new cascade of HIV care for the era of "treat all".
    PLoS Med. 2017;14:e1002268.
    PubMed     Text format     Abstract available


  63. SHARMA M, Barnabas RV, Celum C
    Community-based strategies to strengthen men's engagement in the HIV care cascade in sub-Saharan Africa.
    PLoS Med. 2017;14:e1002262.
    PubMed     Text format     Abstract available


  64. MCNAIRY ML, Abrams EJ, Rabkin M, El-Sadr WM, et al
    Clinical decision tools are needed to identify HIV-positive patients at high risk for poor outcomes after initiation of antiretroviral therapy.
    PLoS Med. 2017;14:e1002278.
    PubMed     Text format     Abstract available


  65. GENG EH, Peiris D, Kruk ME
    Implementation science: Relevance in the real world without sacrificing rigor.
    PLoS Med. 2017;14:e1002288.
    PubMed     Text format     Abstract available


    February 2017
  66. MIKKELSEN E, Hontelez JA, Jansen MP, Barnighausen T, et al
    Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
    PLoS Med. 2017;14:e1002240.
    PubMed     Text format     Abstract available


  67. BEKKER LG, Gray GE
    Hope for HIV control in southern Africa: The continued quest for a vaccine.
    PLoS Med. 2017;14:e1002241.
    PubMed     Text format     Abstract available


    November 2016
  68. MASTERS SH, Agot K, Obonyo B, Napierala Mavedzenge S, et al
    Promoting Partner Testing and Couples Testing through Secondary Distribution of HIV Self-Tests: A Randomized Clinical Trial.
    PLoS Med. 2016;13:e1002166.
    PubMed     Text format     Abstract available


  69. FAIRALL LR, Folb N, Timmerman V, Lombard C, et al
    Educational Outreach with an Integrated Clinical Tool for Nurse-Led Non-communicable Chronic Disease Management in Primary Care in South Africa: A Pragmatic Cluster Randomised Controlled Trial.
    PLoS Med. 2016;13:e1002178.
    PubMed     Text format     Abstract available


  70. SHUBBER Z, Mills EJ, Nachega JB, Vreeman R, et al
    Patient-Reported Barriers to Adherence to Antiretroviral Therapy: A Systematic Review and Meta-Analysis.
    PLoS Med. 2016;13:e1002183.
    PubMed     Text format     Abstract available


    October 2016
  71. KUNKEL A, Cobelens FG, Cohen T
    Tradeoffs in Introduction Policies for the Anti-Tuberculosis Drug Bedaquiline: A Model-Based Analysis.
    PLoS Med. 2016;13:e1002142.
    PubMed     Text format     Abstract available


  72. BEYRER C, Makofane K, Orazulike I, Diouf D, et al
    Towards Equity in Service Provision for Gay Men and Other Men Who Have Sex with Men in Repressive Contexts.
    PLoS Med. 2016;13:e1002154.
    PubMed     Text format     Abstract available


    September 2016
  73. HORTON KC, MacPherson P, Houben RM, White RG, et al
    Sex Differences in Tuberculosis Burden and Notifications in Low- and Middle-Income Countries: A Systematic Review and Meta-analysis.
    PLoS Med. 2016;13:e1002119.
    PubMed     Text format     Abstract available


  74. MADANITSA M, Kalilani L, Mwapasa V, van Eijk AM, et al
    Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlle
    PLoS Med. 2016;13:e1002124.
    PubMed     Text format     Abstract available


  75. BORQUEZ A, Cori A, Pufall EL, Kasule J, et al
    The Incidence Patterns Model to Estimate the Distribution of New HIV Infections in Sub-Saharan Africa: Development and Validation of a Mathematical Model.
    PLoS Med. 2016;13:e1002121.
    PubMed     Text format     Abstract available


  76. MOFENSON LM
    Tenofovir Pre-exposure Prophylaxis for Pregnant and Breastfeeding Women at Risk of HIV Infection: The Time is Now.
    PLoS Med. 2016;13:e1002133.
    PubMed     Text format     Abstract available


  77. MUGWANYA KK, Hendrix CW, Mugo NR, Marzinke M, et al
    Pre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant Absorption.
    PLoS Med. 2016;13:e1002132.
    PubMed     Text format     Abstract available


    August 2016
  78. ROSEN S, Fox MP, Larson BA, Sow PS, et al
    Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda.
    PLoS Med. 2016;13:e1002106.
    PubMed     Text format     Abstract available


  79. BINAGWAHO A, Kankindi I, Kayirangwa E, Nyemazi JP, et al
    Transitioning to Country Ownership of HIV Programs in Rwanda.
    PLoS Med. 2016;13:e1002075.
    PubMed     Text format     Abstract available


  80. IWUJI CC, Orne-Gliemann J, Larmarange J, Okesola N, et al
    Uptake of Home-Based HIV Testing, Linkage to Care, and Community Attitudes about ART in Rural KwaZulu-Natal, South Africa: Descriptive Results from the First Phase of the ANRS 12249 TasP Cluster-Randomised Trial.
    PLoS Med. 2016;13:e1002107.
    PubMed     Text format     Abstract available


  81. BAETEN JM, Heffron R, Kidoguchi L, Mugo NR, et al
    Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1-Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda.
    PLoS Med. 2016;13:e1002099.
    PubMed     Text format     Abstract available


  82. KILMARX PH, Simbi R
    Progress and Challenges in Scaling Up Laboratory Monitoring of HIV Treatment.
    PLoS Med. 2016;13:e1002089.
    PubMed     Text format     Abstract available


  83. HABIYAMBERE V, Ford N, Low-Beer D, Nkengasong J, et al
    Availability and Use of HIV Monitoring and Early Infant Diagnosis Technologies in WHO Member States in 2011-2013: Analysis of Annual Surveys at the Facility Level.
    PLoS Med. 2016;13:e1002088.
    PubMed     Text format     Abstract available


  84. JAY J, Buse K, Hart M, Wilson D, et al
    Building from the HIV Response toward Universal Health Coverage.
    PLoS Med. 2016;13:e1002083.
    PubMed     Text format     Abstract available


    June 2016
  85. ROSEN S, Maskew M, Fox MP, Nyoni C, et al
    Correction: Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    PLoS Med. 2016;13:e1002050.
    PubMed     Text format     Abstract available


  86. ROCHAT TJ, Houle B, Stein A, Coovadia H, et al
    Exclusive Breastfeeding and Cognition, Executive Function, and Behavioural Disorders in Primary School-Aged Children in Rural South Africa: A Cohort Analysis.
    PLoS Med. 2016;13:e1002044.
    PubMed     Text format     Abstract available


    May 2016
  87. ROSEN S, Maskew M, Fox MP, Nyoni C, et al
    Initiating Antiretroviral Therapy for HIV at a Patient's First Clinic Visit: The RapIT Randomized Controlled Trial.
    PLoS Med. 2016;13:e1002015.
    PubMed     Text format     Abstract available


  88. MARSEILLE E, Kahn JG
    A Revolution in Treatment for Hepatitis C Infection: Mitigating the Budgetary Impact.
    PLoS Med. 2016;13:e1002031.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: